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Abstract.  The pattern of expression of the protx2(I) 
collagen gene is highly tissue specific in adult mice 
and shows its  strongest expression in bones, tendons, 
and skin. Transgenic mice were generated harboring 
promoter fragments of the mouse proot2(I)  collagen 
gene linked to the Escherichia coli B-galactosidase or 
firefly luciferase genes to examine the activity of these 
promoters during development. A region of the mouse 
proot2(I)  collagen promoter between -2,000 and  +54 
exhibited a pattern of/~-galactosidase activity during 
embryonic development that corresponded to the ex- 
pression pattern of the endogenous proot2(I)  collagen 
gene as determined by in situ hybridization. A  similar 
pattern of activity was also observed with much 
smaller promoter fragments containing either 500 or 
350 bp of upstream sequence relative to the start of 
transcription. Embryonic regions expressing high lev- 
els of/~-galactosidase activity included the bulbus ar- 
teriosus, valves of the developing heart, sclerotomes, 
meninges, limb buds, connective tissue fascia between 
muscle fibers, osteoblasts in newly formed bones, 
fibroblasts in tendons, periosteum, dermis, and perito- 
neal membranes. The pattern of fl-galactosidase activ- 
ity was similar and included within the extracellular 
immunohistochemical localization pattern of trans- 
forming growth factor-ill (TGF-B1). The -315--284 
region of the protx2(I)  collagen promoter was previ- 
ously shown to mediate the stimulatory effects of 
TGF-/~I on the proot2(I)  collagen promoter in DNA 
transfection experiments with cultured fibroblasts.  A 
construct containing this sequence tandemly repeated 
5' to a very short ot2(I) collagen promoter (-40-+54) 
showed preferential activity in tail and skin of 4-wk- 
old transgenic mice. Except for low expression of the 
transgene in bone, this pattern mimics the expression 
of the endogenous protx2(I)  collagen gene. We propose 
the hypothesis that the tissue-specific expression of the 
protx2(I)  collagen gene during embryogenesis is con- 
trolled by both TGF-B1 and cell-specific transcription 
factors; one of these could interact directly or in- 
directly with either the -315--284  or the -40-+54 
segment. 
T 
YPE I collagen is the most abundant extracellular ma- 
trix protein in vertebrates and is a member of a family 
of multiple collagen types. It is a heterotrimer com- 
posed of two od(I) chains and one ot2(I) chain, which are 
coordinately regulated.  Type I collagen is first detected at 
day eight during murine embryonic development (Adamson 
and Ayers, 1979; Leivo et al., 1980) and is crucial for com- 
plete vertebrate development (Adamson, 1982; Reddi et al., 
1984).  Homozygous  disruption  of the protxl(I)  collagen 
gene, caused by the integration  of retroviral DNA into the 
first intron of the mouse gene, results in embryonic lethality 
at 12-13 d of gestation (Schnieke et al., 1983; Harbers et al., 
1984). 
Expression of both prood(I) and protx2(I) collagen follows 
a distinct  tissue-specific  pattern.  RNase protection assays 
show high levels of RNA encoding these polypeptides  in 
bone, tendon, and skin, with much lower levels in other tis- 
sues (Slack et al.,  1991; Goldberg  et al.,  1992). The se- 
quences responsible  for this tissue-specific  regulation have 
not been identified.  However,  several  regions  have been 
identified in the mouse procz2(I) and human, rat, and mouse 
protxl(I) collagen genes that regulate transcription (Karsenty 
et al., 1988; Rossi et al., 1988; Karsenty et al., 1991; Ritzen- 
thaler et al., 1991). Within the 350-bp sequence upstream of 
the start of transcription  of the mouse protx2(I) collagen 
gene, there are several functional  cis-acting elements that 
stimulate proa2(I) gene transcription (Karsenty et al., 1988; 
Hatamochi et al.,  1988; Maity et al.,  1988; Rossi et al., 
1988). A binding  site for CCAAT transcription  factor/nu- 
clear factor-1 (CTF/NF-1) is present at -300. The -300 site 
mediates the effect of TGF-fll, which, when added to fibro- 
blasts in culture, acts to stimulate the activity of a transfected 
tx2(1) promoter-CAT chimeric gene. Mutations  in the NF-1 
site abolish this TGF-B1 inducibility  (Rossi et al.  1988). 
TGF-fll is a potent inducer of Type I collagen expression 
and may play an important role as a developmental regulator. 
TGF-fll  and some of its  related family members are ex- 
pressed in restricted patterns during development (Akhurst 
et al., 1990) and several other family members such as ac- 
tivin and possibly bone morphogenetic  factors may influence 
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ment (Thomsen et al.,  1990; Koster et al.,  1991). 
Tissue culture transfection assays (Schmidt et al.,  1986) 
and transgenic mice (Khillan et al., 1986) have been used to 
identify the regions of the mouse o~2(1) collagen gene that 
confer tissue specificity. The ot2(I) promoter from -2,000 
to +54 directed CAT reporter gene expression in a pattern 
mimicking that of the endogenous Type I collagen genes in 
adult mice (Khillan et al.,  1986). Sequences present in the 
first intron of the ot2(I) collagen gene which had previously 
been reported to contain an enhancer element were not re- 
quired to direct tissue-specific  expression  (Khillan  et al., 
1986; Goldberg et al., 1992). When the region from -350 
to +54 of  the proa2(l) collagen promoter was linked to CAT, 
transgenic mice displayed the same tissue-specific  expres- 
sion pattern, except that expression in the brain was also ob- 
served (Goldberg et ai., 1992). Others have reported that the 
human procxl(I) collagen gene requires 2.3 kb of upstream 
promoter sequences to direct tissue-specific  expression  in 
transgenic mice (Slack  et al.,  1991). Furthermore, the 5' 
flanking region of the prood(I) collagen gene between -3.5 
and -2.3 kb has been implicated in high-level expression in 
osteoblasts  (Pavlin et al.,  1992). 
In this paper, we further define the ability of the procx2(I) 
collagen gene promoter to direct tissue-specific expression 
in  transgenic  mice.  We  have  used  the  /3-galactosidase 
reporter gene to localize transgene expression  during em- 
bryonic development. Through promoter deletions we show 
that 350 bp of promoter sequences linked to ~-galactosidase 
were sufficient to confer a very high degree of tissue and cell 
specificity. This pattern mimicked the distribution of endog- 
enous procx2(I) collagen during development as determined 
by in situ hybridization  and was  similar to the immuno- 
histochemical localization of TGF-/31. A region of the r 
collagen promoter from -315 to -284 which mediates the 
effects of TGF-/31 was tandemly repeated 5' to a short c~2(I) 
collagen promoter (-40-+54) linked to the firefly luciferase 
reporter gene. This chimeric gene showed a high degree of 
tissue-specific  activity in transgenic animals. 
Materials and Methods 
Piasmid Constructions 
Regions of the proa2(l) collagen promoter were inserted upstream of the 
translational start site of a/acZ expression vector (placF) (Mercer et al., 
1991) which contains the mouse protamine gene sequences that supply an 
intron and polyadenylation  signal (see Fig. 1). A 2,054-bp HindIII fragment 
(for -2,000/acZ) from pR40 was subcloned by blunt end ligation into the 
Sinai site of place A 554-bp XbaI to HindIH fragment from PR40 (Rossi 
et al., 1988) was made blunt using the Klenow enzyme and deoxynucleotide 
triphosphates; after addition of ~2~aI linkers this fragn~nt was ligated into 
the M~aI site of placF to create -500/acZ. A 404-bp Bgln to HindIII frag- 
ment, also from PR40 (Rossi et al.,  1988) was similarly ligated into the 
X~I site of placF to create -350/acZ. 
A segment consisting of four tandem copies of the pro~2(I) collagen pro- 
moter sequence from -315 to -284 inserted upstream of the -40-+54 
proot2(I) collagen DNA segment was introduced into the polylinker region 
of the firefly luciferase vector (pA31uc) to create pLAG1 (Goldberg et al., 
1992).  The pA31uc vector contains an SV-40 polyadenylation  signal and 
splice sites 3' to the luciferase gene and a polyndenylation cassette 5' to the 
site in which the promoter region is inserted. In transfe~on studies,  this 
5'polyadenylation segment inhibits read-through transcription (Wood et al., 
1989). 
Generation of Transgenic Mice 
Transgenic  mice were produced by pronuclear injection of gene construct 
into B6D2F2 fertilized eggs (Hogan et al., 1986). The -2,000,  -500, and 
-350/acZ plasmids were digested  with Asp718 and HindIII, and pLAG1 
was cleaved with AatlI and SacI to release the inserts from plasmid vector 
sequences  (see Fig.  1). Founder mice carrying the introduced gene con- 
structions were identified  by Southern analysis  of tail DNA (Southern, 
1975). 
~-galactosidase and Luc~ferase Expression 
/~-galactosidase  activity was  assayed  in collagen-/acZ transgenic mouse 
lines by staining embryos with X-Gal using techniques previously described 
(Mercer et al., 1991). Embryos were stained for 1-2 d. No additional stain- 
ing appeared after 2 d. After staining, embryos were paraffin embedded. 
6-pm-thick sections were counterstained with eosin. 
To examine the expression of the luciferase reporter gene in LAG1 trans- 
genic mice, representative organs from 4-wk-old  animals were dissected 
from surrounding tissue,  placed on dry ice, homogenized  in a buffer con- 
raining 100 mM Tris, pH 7.8, and 1 ram DTT, and microfuged.  The super- 
natant was assayed for luciferase activity in the presence of excess D-lucif- 
erin (0.3 mg/ml), 15 mM MgSO4, 5 mM ATP, and 1 mM DTT. Known 
quantities of luciferase containing fibroblast cell extract were homogenized 
along with tissues from a normal mouse to determine whether these tissues 
contained inhibitors of luciferase activity. No inhibitors of luciferase activ- 
ity were present in any of the mouse tissues.  Measurements were taken 
using a Monolight 2010 luminometer.  Protein levels were measured using 
the Bradford assay with BSA as standard (Bradford,  1976). Results were 
expressed  as luciferase light units per 1 mg of protein. 
In situ Hybridization 
Embryos isolated at 11.5-15.5 d posteoitum (Ell.5 to E15.5) were fixed in 
10% formalin for 24 h or more (depending on size). After dehydration with 
increasing concentrations of ethanol, embryos were embedded in paraffin 
and sectioned onto silane-treated slides at a thickness of 6 ~an. A 200-bp 
PstI-EcoRI  fragment coding  for the COOH-terminal region of the rat 
proof2(1) collagen  gene (pa2R2,  kindly provided by Dr.  David  Rowe, 
University of Connecticut, Farmington, CT) was directionally cloned into 
Bluescript +  (Stratagene  Inc., La Jolla, CA) to give pKa2R2.  Plasmids 
were linearized downstream of the inserted fragment with PstI and antisense 
riboprobes  generated  using  T7  RNA  polymerase.  Similarly,  plasmid 
pKa2R2 was digested with EcoRI, transcribed by T3 RNA polymerase to 
generate sense RNA. Probes were labeled with 3scxS-rUTP  to a specific ac- 
tivity of 105 cpm/~,l. In situ hybridizations were performed as previously 
described (Wikinson et al.,  1987) with the following modifications.  Sec- 
tions were postfixed in 4 % formaldehyde, treated with 40 ~tg/ml proteinase 
K for 7.5 rain, and treated with 0.1 M triethanolamine containing 0.25% 
acetic anhydride  for 10 rain. Slides  were heated for 2 rain at 98~  and 
cooled on ice before hybridization.  The hybridization mix containing 50% 
formamide,  0.3 M NaC1, 1￿  Denhardt, 5 mM EDTA,  10 mM Tris,  10% 
dextran, 10 raM DTT, 10 mM NaHPO4, 500 ~,g/ml tRNA, 200/~g/ml calf 
thymus DNA, and the denatured probe was added to each slide and further 
incubated at 48~  overnight. Sections were treated with RNAse at 37~  for 
30 rain using 20 #g/ml RNAse A and 1/tg/rnl RNAse T1. After washing, 
slides were dipped in a 50% mixture of NTB-2 (Eastman Kodak Co., Roch- 
ester, NY) and 0.6 M NH4Ac, further exposed at 4~  for 3-4 d for autora- 
diography,  and subsequently developed.  All sections were counter-stained 
with hematoxylin and photographed under darkground illumination. 
Results 
Generation of Transgenic Mice 
Transgenic  mouse  lines  were  generated  using  the  mouse 
oL2(I) collagen promoter-reporter gene constructions shown 
in Fig.  1.  Founder mice and progeny carrying the various 
gene constructions were identified. The number of copies of 
the transgenes in each line were characterized by Southern 
blot analysis (Table I).  Four out of eight lines carrying the 
construct containing 2,000 bp of the ~2(I) collagen promoter 
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Figure 1. Representations  of DNA constructs used to generate a2(I) 
coUagen-lacZ and a2(I) collagen-luciferase transgenic mice. See 
Materials and Methods for details. 
fused to the/acZ gene exhibited detectable/3-galactoside ac- 
tivity as assayed by X-gal staining of embryos. Three out of 
seven lines carrying the construction containing 500 bp up- 
stream  of the  start  of transcription  expressed  detectable 
/3-galactosidase  activity. Three out of eight lines bearing the 
construct containing the -350-bp promoter, showed trans- 
gene expression. Variations were seen in the levels of trans- 
gene expression between lines with the same promoter con- 
struction and are likely influenced by the site of transgene 
integration.  Overall,  however,  there  was  a  remarkable 
similarity in the pattern of expression of/~-galactosidase in 
these different strains. 
In contrast to the/acZ-containing strains, which were ex- 
amined at various stages during embryonic development, 
transgenic mouse lines created with the luciferase reporter 
gene  were  tested by measuring luciferase activity in  in- 
dividual tissue of 4-wk-old founder mice (see Materials and 
Methods for details). At this age mice show higher levels of 
prot~l(I)  collagen RNA than at later times  (Slack et al., 
1991). Four of the five founders that were positive for the lu- 
ciferase gene by Southern hybridization expressed the chi- 
meric gene containing the tandemly repeated  -315--284 
sequence of the ct2(I) collagen promoter. This higher per- 
centage of expression for mice carrying the luciferase trans- 
gene than for mice with a/~-galactosidase transgene can be 
accounted for by the much greater sensitivity of the assay for 
the luciferase enzyme. 
t~2(I) Collagen LacZ Transgenes 
Direct 1Issue-specific Expression during 
Murine Development 
The distinct transgene expression pattern directed by the 
construction harboring a  -2,000-bp promoter is shown in 
whole embryos in Fig. 2. At 9.5 d of embryonic development 
(E9.5; Fig. 2 A) transgene expression was first seen in the 
bulbus arteriosus, the most anterior segment of the tubular 
embryonic heart (Fig. 2 A).  1 d later at E10.5 (Fig. 2 B), a 
more pronounced X-gal staining appeared at the base of the 
limb buds and in the visceral arches. The upper ridge of the 
region of the head bordering the fourth ventricle and the up- 
per region above the notochord also showed B-galactosidase 
expression.  Staining in the telencephalic region was also 
seen in some lines. At E12.5 (Fig. 2 C), flaring and indenta- 
tion of the future digits occurred. A distinct radiating pattern 
of X-gal staining appeared in the developing digits. Marked 
staining was also visible in regions of the limbs closer to the 
body. These regions represent areas of early mesenchymal 
tissue condensation in forming bones and joints. A diffuse 
stain at the back of the head corresponds to staining in the 
developing meninges. Segmented expression in the sclero- 
tomes was visible in the tail of the embryo; slightly rostral 
to this, the developing vertebrae show more intense expres- 
sion. Transgene expression was also seen in the nasal region 
and forehead. At E13.5 (Fig. 2 D) digit formation was evident 
with transgene expression further demarcating this event. 
There was transgene expression in a region surrounding the 
areas where the hair follicles of the face (vibrissae) appear. 
Other areas of transgene expression included the external 
portion of the developing ear  (pinna),  tail,  skin,  mesen- 
chymal regions of the mandible, and both cranial and spinal 
meninges evident around the head and above the spinal cord. 
Fig. 2 E exemplifies the transgene expression that occurred 
in the tail and developing limbs of the -2,000 lacZ carrying 
mice at E15.5 (Fig. 2 E). 
Additional  transgenic  lines  were  generated  containing 
truncations  of  the  -2,000-bp  promoter  to  determine 
whether smaller segments would confer similar patterns of 
expression. Two lines carrying the -500 lacZ construct and 
two lines carrying the -350/acZ construct showed/~-galac- 
tosidase expression similar to mice carrying the -2,000-bp 
promoter. Fig. 2, F  and G show the pattern of staining in 
El0.5 and 12.5-d embryos carrying the -350-bp promoter. 
In a few other lines (not shown) B-galactosidase expression 
was  restricted to regions such as the mandibular region, 
meninges, and sclerotomes. In three lines (one harboring the 
-2,000 lacZ construct and two with the -350 lacZ gene) 
small areas of  promiscuous B-galactosidase activity occurred 
in the brain. Otherwise, no inappropriate transgene expres- 
sion was observed. 
Histological Localization of u2(I) Collagen 
LacZ Transgenes 
As with/3-galactosidase staining in whole-mount embryos, 
Table L Copy Number of  Transgenes in Mouse Lines in which There Was a Detectable Level of  Expression of  Either 
~-galactosidase or Luciferase (LAG1) 
-  2000LacZ  -  500LacZ  -  350LacZ  LAG  1 
Line  Copy number  Line  Copy number  Line  Copy number  Line  Copy number 
7  6-8  13  7  13  5  7  3 
16  1  23  1  37  8-10  9  8 
30  1  26  1  40  40  17  30 
38  5  24  20 
Niederreither et al. Lineage-specific Expression of Proc~2(I) Collagen  1363 Figure 2. Expression of the -2,000 and -350/acZ promotor constructs in whole mount embryos. Blue color indicates positive staining 
for ~3-galactosidase.  A-E show expression for the -2,000 lacZ construction for line 7; Fand G show comparable expression with the -350 
/acZ construction line 3Z (A) E9.5 embryo showing expression in the primitive heart (arrow). (B) El0.5 embryo showing expression in 
limb buds (Ib) and visceral arches (va). (C) E12.5 embryo showing lacZ expression in developing digits (dig), meninges (mn), and sclero- 
tomes (sc). (D) E13.5 -2,000 tacZ embryo showing expression in digits, connective tissue surrounding developing hair follicles in the 
nose, meninges (mn), ear, and tail.  (E) E15.5 -2,000/acZ embryo showing expression in tail and developing foot. F and G show El0.5 
and E12.5 -350 lacZ embryos showing expression comparable  with the  -2,000 lacZ expression shown in B and C, respectively. 
the  transgenic  embryos carrying  the  -2,000,  -500,  and 
-350 a2(I) collagen promoter-lacZ construct showed strik- 
ing similarities in ~3-galactosidase  staining when further ex- 
amined  histologically  (see  Table II).  Staining  clearly oc- 
curred  in  very discrete  areas  of tissues.  The  histological 
sections shown in Fig. 3 illustrate some examples of this ex- 
quisite cell specificity. At El0.5,/3-galactosidase expression 
was evident in the mesenchymal cells of the bulbus arteriosus 
(Fig.  3 A).  A  day later in development, at Ell.5,  /3-galac- 
tosidase expression was found in the sclerotomes (Fig. 3 B). 
At this stage, staining in the heart was also restricted to cells 
of the endocardial  cushion,  a  precursor to the developing 
The Journal of Cell Biology, Volume 119,  1992  1364 Figure 3. o~2(I)  collagen-/acZ fusion gene expression in sagittal sections of early embryos as indicated by blue stain. (A) Transgene expres- 
sion at E10.5 day in bulbus arteriosus of developing heart (-2,000/acZ, line 7). (B) Ell.5 ~pression in sclerotomes  (-500/acZ, line 
23).  (C) Ell.5 expression in heart valves (-500/acZ, 1me 23).  (D) Expression in the bulbus arteriosus at E12.5 (-350/acZ, line 37). 
(E)/acZ expression in the meninges overlying the brain at B12.5 (-350/acZ, line 37). (F) Transgene expression restricted to the fibro- 
blastic connective tissue (f~) surrounding the submandibular gland at E13.5 days (-350/acZ, line 37). Note the absence of expression 
in the central parenchymal  glandular  tissue. Bars,  100 #m. 
Niederreither et al. Lineage-specific F.,zpression of ProoL2(1) Collagen  1365 Figure 4.  ,v2(I) eollagen-/acZ expression later in development. (.4) Transgene expression in tail tendon at E15.5 (-2,000/acZ, line 7). 
LacZ expression in the extracellular region probably indicates diffusion of stain. (B)/~-galactosidase expression in fibroblasts of the en- 
domysium surrounding muscle fibers at E15.5 (-2,000/acZ construction, line 7).  (C) "lYansgene expression in connective tissue cells 
interspersed between muscle fibers of the tongue in an E14.5 embryo (-500/acZ, line 23). (D) Transgene expression in osteoblasts (os) 
of the mandibular bone at E15.5 (-2,000 lacZ, line 30). Note the lack of r  coUagen-/acZ expression in adjacent chondrocytes in 
Meckels cartilage (mc). (E) E15.5 expression in the periosteum of the ribs (rb) (-2,000/acZ, line 30). (F) LacZ expression in the dermis 
(din) and underlying connective tissue (fib) in newborn mouse skin (-2,000 lacZ, line 30). Bars,  100 tLm. 
atrioventricular heart valves,  as  well as  in the fibroblasts 
within the subendothelial layer of the endocardium but was 
absent in the myocardium itself (Fig.  3  C). 
At E12.5, transgene expression in cells of the heart valves 
and bulbus arteriosus was apparent (Fig. 3 D). Expression 
in meningeal cells overlaying the brain (Fig. 3 E) and spinal 
cord was also seen. The specificity of the pattern of expres- 
sion  conferred by  the  o~2(I) collagen promoter was  also 
demonstrated by X-gal staining which is restricted to the 
fibmblast-rich matrix surrounding the submandibular gland, 
and is not visible within the central parenchymal tissue (Fig. 
3 F). 
At  E15.5,  when  organogenesis  is  essentially  complete, 
cell-specific transgene expression was again clearly appar- 
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or2(1) Collagen [3-galactosidase Transgenes 
Age  Structure  -2,000LacZ -500LacZ  - 350LaeZ 
E11.5  Endoeardium  +  +  + 
Heart valves  +  +  + 
Sclerotomes  +  +  + 
E13.5  Meninges  +  +  + 
Capsule of  +  ND  + 
submandibular 
gland 
E15.5  Fascia between  +  +  + 
muscles 
E17.5  Dermis  +  +  + 
Osteoblasts  +  +  + 
Odontoblasts  ND  +  ND 
ent. Fig. 4 A shows that the zone of densely arranged fibro- 
blasts in tail tendon stained for/3-galactosidase. Transgene 
expression was also found solely in the fibroblasts of the 
endomysium surrounding individual muscle fibers (Fig. 4 
B). Fig. 4  C shows similar transgene expression in connec- 
tive tissue cells interspersed between skeletal muscle fibers 
of the tongue. At E15.5, ossification is beginning to occur in 
certain bones such as the mandibular bone which showed 
one of the earliest intramembranous ossification regions. 
LacZ expression was seen in osteoblasts adjacent to newly 
formed bone matrix, but no expression was evident in the 
chondrocytes of  Meckels cartilage (Fig. 4 D). In the develop- 
ing ribs, before the onset of endochondral ossification, trans- 
gene expression was found in the fibrous periosteum but not 
in the chondrocytes under the periosteum (Fig. 4  E). 
Transgene expression in newborn mouse skin is shown in 
Fig. 4 F. ~galactosidase expression was found in the fibro- 
blasts of the dermis and in cells of the subdermal connective 
tissue but was absent in the keratinized epithelial cells. 
The discrete ceil-specific activity observed with the -2,000- 
bp promoter was exactly reproduced with the  -500- and 
-300-bp  promoter  throughout  embryonic  development. 
Both the -500- and -350-bp promoters were active in osteo- 
blasts in newly formed  bones (data not shown). Very recently, 
we have also observed that the -500-bp promoter was active 
in odontoblasts (Table II). 
The very discrete, tissue- and cell-specific X-gal staining 
at different times of development is similar and is included 
in the patterns of extracellular TGF-~  expression during 
mouse development (Heine et al.,  1987;  Flanders et al., 
Figure 5. In situ hybridization for ~2~ collage RNA in the embryonic mouse. SagiRal sections were hybridized with antisense rat a2(I) 
collagen RNA and photographed under dark-field illumination. (.4) Ell expression in sclerotomes. (B) E12.5 expression in meninges above 
brain. (C) E13.5 expression in connective tissue cells interspersed between muscle fibers of  the tongue. (D) E14.5 expression in periosteum 
of ribs. Bars,  100/~m. 
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shown). For instance, an identical pattern of immunoreac- 
tive TGF-/$1 was found, in the developing cardiac cushion at 
Ell.5 (see Fig. 3 B for transgene expression). A similar dis- 
crete localization of TGF-/~I was also found in sclerotomes 
at Ell.5  (Heine et al.,  1987; data not shown). 'I'GF-/31 is 
present in the extracellular matrix surrounding meningeal 
fibroblasts in an identical pattern as was seen for fl-gaiactosi- 
dase in Fig. 3 E. Other examples of this striking similarity 
between TGF-B1 localization and X-gal  staining are in the 
connective tissue of fascia separating groups of myotubes 
(Fig. 4, B and C) and in the newly formed ossification cen- 
ters (Fig. 4 D) (Heine et al., 1987; R. D'Souza, unpublished 
observation). 
The Expression Pattern of the a2(I) CoUagen-LacZ 
Transgenes Mimics That of the Endogenous pro~2(I) 
Collagen Gene 
Expression of the endogenous mouse ~2(I) collagen gene 
was examined by in situ hybridization of embryos using an 
antisense rat pro~2(I) collagen RNA probe. The pattern of 
embryonic proot2(I) collagen RNA was identical to the pat- 
tern of procd(I) collagen RNA (Cheah et al., 1991 and data 
not shown). Expression of the fl-galactosidase transgene was 
very similar to the pattern of expression of the endogenous 
gene, although in some areas, such as the peritoneal mem- 
branes, X-gai staining was not as uniform as the pattern that 
was seen by in situ hybridization. Fig. 5 shows representative 
examples that highlight the similarities between the tissue- 
specific  expression  of the  endogenous proa2(I)  collagen 
gene and that of the transgenic construction. At Ell, the in 
situ hybridizations showed discrete signals of expression in 
the sclerotomal cells (Fig. 5 A), in a similar yet broader pat- 
tern than the X-gal staining shown in Fig. 3 B. Fig. 5 B shows 
high signal intensity in meningeal fibroblasts at E12.5  in a 
pattern that mimics transgene expression shown in Fig. 3 E. 
Similarly, hybridization in fibroblasts within the connective 
tissue surrounding the muscles of the tongue (Fig. 5 C) at 
E14.5 was very similar to the X-gal staining of Fig. 4  C. At 
this stage of development, periosteal cells surrounding the 
developing ribs show a strong hybridization signal (Fig. 5 D) 
that, again was similar to the staining in transgenic embryos 
(Fig. 4 E), and hybridization occurred in fully differentiated 
osteoblasts within the mandible (data not shown), like that 
seen for fl-galactosidase staining (Fig. 4 D). 
A Region of the ~2(I) Collagen Promoter from 
-315 to -284 Tandemly repeated Upstream of  a 
Minimal Promoter Can Direct Luciferase Expression 
in a tissue-Specific Manner 
Previous transient expression studies using cultured fibro- 
blasts had indicated that a region within the ot2(I) collagen 
promoter between -315 and -284 mediates the increased 
activity of a transfected ~2(I) collagen promoter in response 
to TGF-~I (Rossi et al., 1988). To examine the possible role 
of  this region in directing the tissue-specific expression of  the 
ot2(I) collagen  promoter, tandem copies of  this sequence were 
inserted upstream of a very short a2(I) collagen promoter 
(-40-+54)  linked to the highly sensitive firefly luciferase 
reporter gene (Fig. 1). The short promoter contains a TATA 
dement to which the general transcription factor TFIID pre- 
Table 111. Luciferase  Activity (Luciferase  Light U/mg 
Protein) of  LAG1 Transgenic  Mice at 4 wk of  Age 
LAG1-7  LAG1-9  LAGI-17  LAGI-24 
%  %  %  % 
Tail  100  100  100  100 
Skin  15  189  24  27 
Calvaria  6.7  1.9  7.4  1.1 
Liver  0.2  0.1  0.5  0 
Muscle  0.2  7  4.0  0 
Heart  0.3  0.5  4.0  0.1 
Lung  0  0.2  7.7  0.2 
Brain  0.9  5.1  9.4  11.3 
Testes  27  1.2  17.5  2.2 
Kidney  0  0.3  2.8  0.1 
Thymus  0  0.2  1.2  0.2 
Small Intestine  0.1  0.5  9.6  0 
Luciferase  values  in  the  different  tissues  are  represented  as percent  of the 
values in tail. Luciferase light U/rag protein in tail were 41,400 for LAG1-7, 
781,000  for LAG1-9,  96,500  for LAGI-17, and 922,200  for LAG1-24. 
sumably  binds.  In  transient  expression  experiments  of 
fibroblasts in culture, the  -40-+54  segment itself is only 
1%  as active as the  -350-bp  promoter (Goldberg et al., 
1992).  Mice, positive for the transgene, were killed at 4 wk 
of age and assayed for luciferase activity in various tissues 
(Table HI). In all four founders, transgene expression was 
highest in the tail. Expression in the skin, though more vari- 
able, was also elevated. However, the expression of  the trans- 
gene did not mimic the high level of  endogenous Type I colla- 
gen RNA found in calvaria. This may suggest that a promoter 
element necessary for high expression of the transgene in 
bone is absent from this construction. Tissues that have very 
low levels of endogenous t~2(I) collagen RNA, such as liver, 
lung, and kidney (Goldberg et al., 1992),  also showed very 
low levels of luciferase activity. Moderate to low levels of lu- 
ciferase activities were found in brain in three founders and 
in several  other tissues in some founders. These activities 
could be attributed to the integration site of the transgene 
since none were consistent across all lines.  These results 
suggest that the  -315--284  sequence plays an important 
role in mediating the activity of the o~2(I) collagen gene in 
skin and tail. The lack of high level expression of LAG1 in 
bone warrants further study. 
Discussion 
Expression of the Type I collagen genes follows a specific 
and discrete pattern. The present study was performed to ex- 
amine in detail the tissue-specific activity of promoter seg- 
ments of the gene for the mouse oL2 chain of Type I collagen 
during embryonic development and to determine which min- 
imal  sequences  were  capable  of conferring this  discrete 
tissue-specific activity. The following three major conclu- 
sions can be drawn from this study: 
First, although the activity of the -350-bp promoter was 
generally less than that of the -2,000-bp promoter, the pat- 
tern of expression of the -350-bp promoter-/acZ chimeric 
gene was the same as that of the -2,0O0-bp promoter. Both 
clearly mimicked the expression of the endogenous gene 
during  embryonic development.  Hence,  the  segment be- 
tween -350 and +54 of the mouse ot2(l) collagen promoter 
contained sufficient information to confer correct temporal 
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reporter  gene.  This  expression  was also  remarkably  cell 
type-specific, e.g.,  when the proa2(I)  collagen  gene was 
transcriptionally  active in a tissue such as muscle, transgene 
expression was limited to the fibroblasts in the endomysium 
surrounding  the muscle fibers. Since the/acZ promoter con- 
struction containing the -350-+54 segment was also active 
in osteoblasts, sufficient information  existed in this segment 
to direct bone-specific transgene  expression. 
The spatial and temporal activity of the proa2(I) collagen 
promoter  resembled  closely  the  extracellular  immuno- 
histochemical localization  of TGF-/31 during embryonic de- 
velopment (Heine et al.,  1987; Flanders et al.,  1989). It is 
likely that regardless of the exact location of the ceils where 
TGF-/31 is synthesized,  its extracellular  localization  is criti- 
cal for its function during embryonic development.  Further- 
more,  several  lines  of evidence suggest that control of the 
amounts of active TGF-/31 in the extracellular  matrix avail- 
able for interaction  with its signaling  receptors is a highly 
regulated process (for review see Massague,  1990). 
Second, when a segment of the a2(I) collagen promoter 
between -315 and  -284 was tandemly repeated upstream 
of a very short ot2(I) collagen promoter (-40-+54),  itself 
linked to the luciferase gene, this chimeric gene displayed a 
high degree of tissue-specific expression in 4-wk-old founder 
mice. It should be noted, however, that this construct was 
only poorly expressed in bones, suggesting that an additional 
sequence may be needed to determine the correct activity of 
this promoter in osteoblasts.  Since the -350/acZ chimeric 
gene was active in osteoblasts, it is likely that such a putative 
bone-specific element would be located within this -350-bp 
segment.  The promoter with the tandemly repeated -315- 
-284 sequence was much less active than the -2,000- and 
-350-bp promoters and we were unable to examine its activ- 
ity in transgenic embryos when it was linked to a/~-galactosi- 
dase reporter gene (data not shown).  Our results,  however, 
suggest  an important  role for either  the  -315--284  se- 
quence or the -40-+54 sequence or both in conferring  tis- 
sue specificity. It is clear that other cis-acting elements exist 
within the -350-bp proximal promoter and probably outside 
of it which contribute to the overall strength of the promoter. 
The observed correlation between the tissue-specific  spa- 
tial and temporal activity of the a2(I) collagen promoter and 
the presence of immunoreactive extracellular  TGF-~ is not 
simply coincidental but suggests a  role for TGF-/~I in the 
tissue-  and  cell-specific  activity of the proot2(I)  collagen 
gene during embryonic development.  Several other observa- 
tions support this hypothesis.  TGF-/31 increases the steady- 
state levels of type I collagen RNAs in fibroblasts in culture 
(Raghow et al.,  1987; Ignotz et al.,  1987; Massague et al., 
1990).  When  injected  subcutaneously in  newborn mice, 
TGF-/~I also increases the accumulation  of type I collagen 
at the site of injection  (Roberts  et al.,  1986).  In addition, 
TGF-/31 was shown to stimulate the activity of a -2,000-bp 
mouse a2(I) collagen promoter chimeric genes in transient 
expression experiments  of fibroblasts  (Rosa et al.,  1988). 
The same -315--284 segment of the oe20) collagen pro- 
moter that was used in a short promoter construction con- 
serving a high degree of tissue specificity in transgenic mice, 
could mediate the effects of TGF-/31 on the activation  of a 
transfected proot2(I) collagen promoter (Rossi et al., 1988). 
TGF-~I is a member of a family of polypeptides of which 
several have important roles in early embryonic decisions. 
Both activins  (Thomsen et al.,  1990) and TGF-/32 (Rosa et 
al.,  1988)  have  been  shown  to  induce  the  synthesis  of 
mesodermic markers in early frog embryos. The temporal 
and spatial correlation between the activity of the a2(I) col- 
lagen promoter-/acZ transgene,  the expression of endoge- 
nous Type I collagen genes, and the extracellular  localization 
of TGF-/31 during  embryonic development  in  the  mouse 
(Heine et al., 1987; Flanders et al., 1989; Heine et al., 1990; 
R. D'Souza, unpublished results),  together with the ability 
of TGF-/31 to activate the ct2(I) collagen promoter in fibro- 
blasts in culture, suggest that Type I collagen genes may con- 
stitute an important end point in the pathways controlled by 
TGF-/31. Type I collagen is a major structural  protein during 
embryonic development. Along with Type I collagen proteins, 
other collagen proteins,  metalloproteinases,  and protease in- 
hibitors are synthesized during fibroblast differentiation.  The 
synthesis  of these other components is also controlled by 
TGF-/31 in fibroblasts  in culture (for review see Roberts et 
al.,  1988). 
Our working  model is that the tissue-specific  activity of 
the Type I collagen  genes during  embryonic development 
would be controlled both by TGF-/31 and  by cell-specific 
transcription  factors that  include one which would bind, 
directly or indirectly, either to the -315--284 sequence or 
to  the  -40-+54  segment.  This  factor  still  needs  to  be 
identified.  Our experiments  also raise the question whether 
TGF-/31 induces the differentiation of fibroblasts from more 
primitive  mesenchymal  ceils  during  embryonic  develop- 
ment.  Since  in  many  tissues  the  patterns  of  immuno- 
histochemical  localization of TGF-~2 and TGF-~3 as well as 
the distribution of the corresponding transcripts  overlap with 
those of TGF-/31 (Petton et al.,  1990; Pelton et al.,  1991; 
Schmid et al., 1991), it is possible that these factors also act 
in stimulating  fibroblast  differentiation  and Type I collagen 
expression. 
It is difficult to estimate the overall level of expression of 
the/acZ transgenes  driven by prot~2(I) collagen promoters. 
Indeed, the observed activity of/~-galactosidase is dependent 
on the rate of synthesis oflacZ mRNA but also on its stability 
and on the stability of the E. coli #-galactosidase itself. Fur- 
thermore since X-gal staining was performed on whole em- 
bryos estimation of the levels of transgene expression, espe- 
cially in less accessible tissues of older embryos, may not be 
accurately represented.  We believe,  nonetheless,  that  ex- 
pression of the transgenes  that were tested was weaker than 
that of the endogenous proot2(I) collagen gene. Transfections 
of DNA into fibroblasts in culture using promoter construc- 
tions linked to either the CAT or the firefly luciferase gene 
have indicated  that even the a20) collagen promoter con- 
structions  containing  -2,000 bp were considerably weaker 
than similar  al(I) collagen promoters, long-terminal  repeat 
viral promoters, or a SV-40 early promoter (Schmidt et al., 
1986; Goldberg et al.,  1992). Therefore,  it is possible that 
the proximal 2,000 bp of  the t~2(I) collagen promoter, though 
tissue specific, lack appropriate enhancer regions necessary 
to direct high-level expression that are located elsewhere.  A 
locus control region located ~40 kb 5' from the/3-globin 
gene, confers high-level tissue-specific transgene expression 
which is independent  of the site of integration  (Grosveld et 
al.,  1987). 
Our results  in transgenic  mice establish the very high 
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moters. TGF-#5'I plays a major role in eliciting  the excessive 
accumulation of extraeellular matrix components, including 
Type I collagen, in certain animal models with fibrotic dis- 
eases (Border et al.,  1990).  Hence,  it is possible that the 
same mechanisms which control the synthesis of fibroblast- 
specific  extracellular matrix components during embryonic 
development could also be abnormally  activated in fibrotic 
lesions. 
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